Genome-Wide DNA Methylation Analysis of Human Pancreatic Islets from Type 2 Diabetic and Non-Diabetic Donors Identifies Candidate Genes That Influence Insulin Secretion
Open accessThe DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Impaired insulin secretion is a hallmark of type 2 diabetes (T2D). Epigenetics may affect disease susceptibility. To describe the human methylome in pancreatic islets and determine the epigenetic basis of T2D, we analyzed DNA methylation of 479,927 CpG sites and the transcriptome in pancreatic islets from T2D and non-diabetic donors. We provide a detailed map of the global DNA methylation pattern in human islets, β- and α-cells. Genomic regions close to the transcription start site showed low degrees of methylation and regions further away from the transcription start site such as the gene body, 3'UTR and intergenic regions showed a higher degree of methylation. While CpG islands were hypomethylated, the surrounding 2 kb shores showed an intermediate degree of methylation, whereas regions further away (shelves and open sea) were hypermethylated in human islets, β- and α-cells. We identified 1,649 CpG sites and 853 genes, including TCF7L2, FTO and KCNQ1, with differential DNA methylation in T2D islets after correction for multiple testing. The majority of the differentially methylated CpG sites had an intermediate degree of methylation and were underrepresented in CpG islands (∼ 7%) and overrepresented in the open sea (∼ 60%). 102 of the differentially methylated genes, including CDKN1A, PDE7B, SEPT9 and EXOC3L2, were differentially expressed in T2D islets. Methylation of CDKN1A and PDE7B promoters in vitro suppressed their transcriptional activity. Functional analyses demonstrated that identified candidate genes affect pancreatic β- and α-cells as Exoc3l silencing reduced exocytosis and overexpression of Cdkn1a, Pde7b and Sept9 perturbed insulin and glucagon secretion in clonal β- and α-cells, respectively. Together, our data can serve as a reference methylome in human islets. We provide new target genes with altered DNA methylation and expression in human T2D islets that contribute to perturbed insulin and glucagon secretion. These results highlight the importance of epigenetics in the pathogenesis of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The human methylome in pancreatic islets from 15 T2D and 34 non-diabetic donors. (A) All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. TSS: proximal promoter, defined as 200 bp or 1500 bp upstream of the transcription start site. UTR: untranslated region. CpG island: 200 bp (or more) stretch of DNA with a C+G content of >50% and an observed CpG/expected CpG in excess of 0.6. Shore: the flanking region of CpG islands, 0–2000 bp. Shelf: regions flanking island shores, i.e., covering 2000–4000 bp distant from the CpG island [68]. Global DNA methylation in human pancreatic islets of T2D and non-diabetic donors is shown for (B) each gene region and (C) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. (D) The absolute difference in DNA methylation of 3,116 individual sites, including 2,988 sites with decreased and 128 sites with increased DNA methylation in T2D compared with non-diabetic human islets with q<0.05 based on a FDR analysis. 1,649 sites with an absolute difference in DNA methylation ≥5% are represented by grey bars. (E) Pie chart describing the number of sites that exhibit increased or decreased DNA methylation in T2D compared with non-diabetic human islets with an absolute difference in methylation ≥5% and q<0.05. The degree of DNA methylation is shown for (F) the 1,596 CpG sites with decreased DNA methylation and (G) the 53 sites with increased DNA methylation in T2D vs. non-diabetic islets in comparison to the degree of methylation of all analyzed CpG sites in the human islets using the Infinium HumanMethylation450 BeadChip.](https://figures.cochat.ai/paper-figures/fd8c276c0dc0486e83f24fd1674f0479/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-1.jpg)



![Figure 5 The human methylome in FACS sorted human β- and α-cell fractions. All analyzed DNA methylation sites on the Infinium HumanMethylation450 BeadChip are mapped to gene regions based on their functional genome distribution and CpG island regions based on CpG content and neighbourhood context [68]. Global DNA methylation in whole human islets (n = 4) and purified human β- (n = 3) and α-cell (n = 2) fractions is shown for (A) each gene region and (B) CpG island regions. Global DNA methylation is calculated as average DNA methylation based on all CpG sites in each annotated region on the chip. Data are mean ± SEM.](https://figures.cochat.ai/paper-figures/4b940823eaa34b94a0a86ee0b9008d18/genome-wide-dna-methylation-analysis-of-human-pancreatic-islets-from-type-2-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies of pancreatic islets from nondiabetic donors ( 19 , 20 ) and patients with T2D ( 21 ) have identified epigenetic modifications in genes that potentially affect β-cell function.”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172 · cited 2×
“We next exported the DNA methylation data from GenomeStudio and used Bioconductor [82] and the lumi package [83] for further analyses.”
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 2×
“A false discovery rate (FDR) analysis was used to correct for multiple testing [18,89,90].”
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,266 · cited 1×
“Next a quantile normalization was performed as described [85].”
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Jones, P. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3230 · Cited by 6,061 · cited 2×
“methylation paradox which still remains unexplained [46].”
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673 · cited 1×
“It has previously been established that DNA methylation in differentiated mammalian cells mainly occurs on cytosines in CG dinucleotides [24].”
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011 · cited 1×
“While some researchers have found a decreased b-cell number and increased a-cell number in human T2D compared with nondiabetic islets, others have not found any differences [69–71].”
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives
Chen, L., Magliano, D. J., & Zimmet, P. Z. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.183 · Cited by 2,227 · cited 1×
“physical inactivity, the number of patients with T2D has dramatically increased worldwide [1].”
Research works printed but not linked: 1
- ISNH Sandovici, 2011, Dynamic epigenetic regulation by early-diet and aging of the type 2 diabetes susceptibility gene Hnf4a in pancreatic islets, Proc Natl Acad Sci U S A, 108, 5449
Cited by
Items 301–400 of 531
Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy
Ma, J., Mao, L., Yang, L., Xie, Q., Fan, R., Lu, X., Huang, X., Tong, N., & Duan, Z. (2025) · MedComm · doi:10.1002/mco2.70359 · Cited by 20
“Using the Illumina 450BeadChip, DNA methylation profiling of 15 T2D and 34 ND islets revealed 1649 CpG sites with differential methylation across 853 genes, with 17 located in T2D-associated regions [190].”
The Future of Epigenetics: Emerging Technologies and Clinical Applications
Iyer, K. A., Tenchov, R., Sasso, J. M., Thite, T., Deng, Y., & Zhou, Q. A. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00729 · Cited by 15
Methylation of Tcf712 promoter by high‐fat diet impairs β‐cell function in mouse pancreatic islets
Hu, Y., Shi, P., He, K., Zhu, Y., Yang, F., Yang, M., He, B., & Mao, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2980 · Cited by 10
“creatic islet DNA of diabetes patients, it is unclear whether such aberrant methylation was due to diabetes or other factors.(22,23) The present study provides evidence that consumption of an HFD in vivo in mice can induce aberrant methylation of the Tcf7l2 promoter.”
Role of Epigenetics in the Pathogenesis and Management of Type 2 Diabetes Mellitus
Yahaya, T. (2019) · Translation The University of Toledo Journal of Medical Sciences · doi:10.46570/utjms.vol6-2019-319 · Cited by 11
“Pediatr Rev 36 (1): 1-50 http://pedsinreview.”
InfluentialCask methylation involved in the injury of insulin secretion function caused by interleukin1‐β
Wang, T., Liu, X., Xie, J., Yuan, Q., & Wang, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16041 · Cited by 11
CHABOSSEAU, P. L., Rutter, G. A., & Millership, S. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031000 · Cited by 10
Metabolism as a central regulator of β‐cell chromatin state
Vanderkruk, B., & Hoffman, B. G. (2020) · FEBS Journal · doi:10.1111/febs.15562 · Cited by 11
mTORC1 is required for epigenetic silencing during β-cell functional maturation
Ni, Q., Sun, J., Wang, Y., Wang, Y., Liu, J., Ning, G., Wang, W., & Wang, Q. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101559 · Cited by 11
“Several studies have shown that human islets from donors with type 2 diabetes had reduced DNA methylation and Polycomb-dependent H3K27m3 levels [23,52,53].”
Kurian, S. M., Ferreri, K., Wang, C.-H., Todorov, I., Al-Abdullah, I. H., Rawson, J., Mullen, Y., Salomon, D. R., & KANDEEL, F. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185331 · Cited by 10
Tros, F., Meirhaeghe, A., Hadjadj, S., Amouyel, P., Bougneres, P. F., & Fradin, D. (2014) · Physiological Reports · doi:10.14814/phy2.12076 · Cited by 10
“Recently, 853 differentially methylated genes have been found in human islets from T2D patients compare to controls (Dayeh et al. 2014).”
Sosibo, A. M., Mzimela, N. C., Ngubane, P. S., & Khathi, A. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.10.004 · Cited by 14
Christiansen, C., Potier, L., Martin, T. C., Villicaña, S., Fernandez, J. C., Mangino, M., Menni, C., Tsai, P.-C., Campbell, P. J., Mullin, S., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105096 · Cited by 9
Yohannes, S. (2015) · F1000Research · doi:10.12688/f1000research.6923.1 · Cited by 11
“(4) Similarly, the co-morbidity of disorders closely associated with DM, such as hypertension and cardiac disorders, were taken into consideration by a very limited number of studies only.”
The Roles of Natural Compounds in Epigenetics
Yang, Y., Chi, Z.-H., Gao, R., & Lei, Z. (2018) · Natural Product Communications · doi:10.1177/1934578x1801300835 · Cited by 9
Jung, S. Y., Bhatti, P., & Pellegrini, M. A. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01435-7 · Cited by 10
“Also, considering that age, as measured via epigenetic age [31, 32], influences DNAm, changes in DNAm that are associated with IR account for aging in the methylome and thus may be a better indicator of inter-/intraindividual genomic variability of IR.”
Jiang, C. H., Hu, Y., Wang, S., & Chen, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1145067 · Cited by 9
Nishioka, K., Daidoji, T., & Nakaya, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.136 · Cited by 9
Riches‐Suman, K., Huntriss, J., Keeble, C. M., Wood, I. C., O'Regan, D. J., Turner, N. A., & Porter, K. E. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116677968 · Cited by 9
Cisplatin Exposure Dysregulates Insulin Secretion in Male and Female Mice
Basu, L., Grieco-St-Pierre, L., Ching, M. E. A., Stead, J. D. H., Hanson, A. A., Palaniyandi, J., Vanzyl, E. J., Hoyeck, M. P., McKay, K. S., van Allen, K. A., et al. (2025) · Diabetes · doi:10.2337/db24-0419 · Cited by 10
On the Verge of Precision Medicine in Diabetes
Li, J. H., & Florez, J. C. (2022) · Drugs · doi:10.1007/s40265-022-01774-4 · Cited by 9
“DNA methylation has been demonstrated to contribute to T2D disease susceptibility [75, 76] and conceivably could associate with drug response.”
Genetics and epigenetics of diabetes and its complications in India
Priyadarshini, A., Madan, R., & Das, S. (2023) · Human Genetics · doi:10.1007/s00439-023-02616-3 · Cited by 9
“DNAme has also been reported to be altered in the pancreatic islets of diabetic patients, impacting the pathogenesis of T2DM by affecting insulin production, β cell secretion, and resistance (Dayeh et al. 2014; Volkov et al. 2017).”
Lanktree, M. B., & Hegele, R. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801812-5.00015-9 · Cited by 11
Alhazzaa, R. A., Heinbockel, T., & Csoka, A. B. (2022) · Biochemistry · doi:10.5772/intechopen.104653 · Cited by 11
Sosa-Larios, T. C., Ortega-Márquez, A. L., Rodríguez‐Aguilera, J. R., Vázquez-Martínez, E. R., Domínguez‐López, A., & Morimoto, S. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1138564 · Cited by 12
Vascular Smooth Muscle as a Target for Novel Therapeutics
Porter, K. E., & Riches‐Suman, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0647-9 · Cited by 8
Das, S. K. (2014) · Diabetes · doi:10.2337/db14-0757 · Cited by 10
Personalized Epigenetic Management of Diabetes
Fodor, A., Cozma, A., & Karnieli, E. (2017) · Personalized Medicine · doi:10.2217/pme-2017-0043 · Cited by 13
Michalczyk, A. A., Janus, E. D., Judge, A., Ebeling, P. R., Best, J. D., Ackland, M. J., Asproloupos, D., Dunbar, J., & Ackland, M. L. (2018) · Epigenomics · doi:10.2217/epi-2017-0129 · Cited by 9
Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men
Broholm, C., Ribel‐Madsen, R., Hjort, L., Olsson, A. H., Ahlers, J., Hansen, N. S., Schrölkamp, M., Gillberg, L., Perfilyev, A., Volkov, P., et al. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1669160 · Cited by 9
“A recent genome-wide study of human pancreatic islets pointed to HDAC7 as a candidate gene showing decreased methylation and increased expression in type 2 diabetes.(45) In a rat beta-cell line HDAC7 overexpression impaired insulin secretion and mitochondrial function potentially through interaction with the type 2 di…”
Self-citationHuman embryonic stem cells as anin vitromodel for studying developmental origins of type 2 diabetes
Chen, A. C.-H., Lee, K. F., Yeung, W. S. B., & Lee, Y. L. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i8.761 · Cited by 8
Roza, M., Eriksson, A. N. M., Svanholm, S., Berg, C., & Karlsson, O. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135455 · Cited by 7
Salama, O. E., Rawal, Y. R., Irabor, P., Kassim, H. B., Pylypjuk, C. L., Sellers, E. A. C., Wicklow, B. A., & Jones, M. J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01972-3 · Cited by 8
“Interest-ingly, we also found two T2D DMR sites (one at C20orf3 and the other at RNU5D) and two GDM DMR sites (one at C20orf3 and the other at COMT) that were associated previously with adult T2D [72].”
Epigenetic adaptation of beta cells across lifespan and disease
Manduchi, E., Descamps, H. C., Liu, J., Schug, J., Da, T., Lahori, D., El‐Mekkoussi, H., Lee, M., Feleke, E., Bernstein, D. L., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01495-y · Cited by 7
Kim, J. E., Jo, M.-J., Cho, E., Ahn, S. Y., Kwon, Y., Gim, J., & Ko, G.-J. (2023) · Genes · doi:10.3390/genes14071489 · Cited by 8
“Previous epigenome-wide association studies (EWAS) have identified compound correlations between DNA methylation levels at individual CpG sites and diseases such as cancer [32,33], type II diabetes [34], and Alzheimer’s disease [31,35].”
The impact of site-specific DNA methylation in KCNJ11 promoter on type 2 diabetes
Zhu, M., Huang, Q., Li, H., Zhao, Y., Guo, H., Wang, T., Liu, X., Huang, Y. L., Hu, J., Fang, C., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39934 · Cited by 10
Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report
Ponard, A., Ferreira-Maldent, N., Daneshpouy, M. E., Delain, M., Amraoui, K., Régina, S., Jonville‐Béra, A. ‐., Hérault, O., Colombat, P., & Gyan, E. (2018) · Journal of Medical Case Reports · doi:10.1186/s13256-018-1690-3 · Cited by 7
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
Ling, C. (2022) · Diabetologia · doi:10.1007/s00125-022-05681-x · Cited by 8
“For example, individuals with type 2 diabetes had higher DNMT3B levels in cultured myotubes [5] and decreased TET1 expression in adipose tissue [6] vs tissue from individuals without type 2 diabetes, while palmitate exposure decreased DNMT3A and DNMT1 expression in human pancreatic islets [11].”
Self-citationde Souza, M. L. M., Borçoi, A. R., Dutra, B. A. B., Vieira, T. D. S., Mendes, S. O., Moreno, I. A. A., Quaioto, B. R., Olinda, A. S., Cunha, E. R., Freitas, F. V., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120940 · Cited by 9
Multiplex Biomarker Approaches in Type 2 Diabetes Mellitus Research
Ozanne, S. E., Rahmoune, H., & Guest, P. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6730-8_3 · Cited by 7
Epigenetic dysregulation in pancreatic islets and pathogenesis of type 2 diabetes
Yokoi, N. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12724 · Cited by 7
“Deyeh et al.(2) also conducted a more comprehensive DNA methylation analysis by using the Infinium HumanMethylation450 BeadChip (∼480,000 CpG sites representing ∼1.”
InfluentialEriksen, R., Gibson, R., Aresu, M., Heard, A., Chan, Q. M., Εvangelou, Ε., Gao, H., Elliott, P., & Frost, G. S. (2019) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.74 · Cited by 8
Qie, R., Han, M., Huang, S., Li, Q., Liu, L., Zhang, D., Cheng, C., Zhao, Y., Liu, D., Qin, P., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107829 · Cited by 9
Ren, J., Zhou, L., Li, S., Zhang, Q., & Xiao, X. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00200.2024 · Cited by 9
Munns, S., Brown, A. D. H., & Buckberry, S. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1502640 · Cited by 6
Lu, Y., Yu, T., Hsuan, C., Hsu, C., Hung, W., Wang, C.-P., Tang, W.-H., Cheng, M.-C., Chung, F., Lee, Y.-J., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15162110 · Cited by 7
“These epigenomic factors regulate gene expression and may influence the functional impact of rs7903146 in a tissue-specific manner, particularly in pancreatic islets and adipose tissue [46].”
MASLD, diabetes and PMOS across the female life stages
Stener‐Victorin, E., Carlsson, S., Hagström, H., & Taebnia, N. (2026) · Diabetologia · doi:10.1007/s00125-026-06761-y · Cited by 7
Imprinted Genes Impact Upon Beta Cell Function in the Current (and Potentially Next) Generation
Villanueva-Hayes, C., & Millership, S. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.660532 · Cited by 7
He, Y., Li, Y., Zhang, J., Chen, L., Li, J., Zhang, M., Zhang, Q., Lü, Y., Jiang, J., Zhang, X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873012 · Cited by 6
“pancreatic islets from type 2 diabetes identified 1,649CpG sites and 853 genes with differential DNAmethylation, but none was related to the FURIN gene (16).”
Dichotomy in the Impact of Elevated Maternal Glucose Levels on Neonatal Epigenome
Lim, I. Y., Lin, X., Teh, A. L., Wu, Y., Chen, L., He, M., Chan, S., MacIsaac, J. L., Chan, J. K. Y., Tan, K. H., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab710 · Cited by 7
Engström, K. S., Nilsson, Å. L., Ofori, J. K., Wierup, N., Bacos, K., & Ling, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-21595-1 · Cited by 7
Self-citationBurton, M. A., Garratt, E. S., Hewitt, M., Sharkh, H. Y., Antoun, E., Westbury, L. D., Dennison, E. M., Harvey, N. C., Cooper, C. C., MacIsaac, J. L., et al. (2023) · Skeletal Muscle · doi:10.1186/s13395-023-00326-y · Cited by 5
“…suggested to act at least in part through epigenetic processes to modulate IR/T2D risk, with genome-wide DNA methylation analyses showing altered methylation of key regulators of glucose metabolism in both pancreatic islet cells and muscle tissue of individuals with prediabetes and T2D [13, 14].”
Wang, J., Li, X., Geng, J., Wang, R., Ma, G., & Liu, P. (2025) · Hereditas · doi:10.1186/s41065-025-00385-9 · Cited by 6
Nagao, M., Asai, A., Eliasson, L., & Oikawa, S. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0253 · Cited by 7
Self-citationEpigenetics and diabetes mellitus
Rehan, M. (2016) · The Egyptian Journal of Internal Medicine · doi:10.4103/1110-7782.193890 · Cited by 7
“Dayeh et al. (2014) [20] provided new target genes with altered DNAmethylation and expression in type 2 diabetes mellitus islets that contribute to perturbed insulin and glucagon secretion.”
Epigenetics and the role of nutraceuticals in health and disease
El-Sayed, A., Aleya, L., & Kamel, M. S. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-25236-w · Cited by 7
“These epigenetic modulations are the consequences of persistent hyperglycemia (Brasacchio et al. 2009; Dayeh et al. 2014; Godfrey et al. 2011; Tateishi et al. 2009; Villeneuve and Natarajan 2010; Wren and Garner 2005).”
Sharma, S., & Bhonde, R. R. (2023) · Epigenomics · doi:10.2217/epi-2023-0302 · Cited by 6
Bhat, S., Mallya, S. P., Varghese, V. K., Jayaram, P., Chakrabarty, S., Joshi, K., Nesari, T. M., & Satyamoorthy, K. (2016) · Gene · doi:10.1016/j.gene.2016.09.019 · Cited by 5
Insulin Action, Insulin Resistance, and Their Link to Histone Acetylation
Balcerczyk, A., Chriett, S., & Pirola, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_57-1 · Cited by 6
Christodoulou, M. S., Thomas, A., Poulain, S., Vidaković, M., Lahtela-Kakkonen, M. K., Matulis, D., Bertrand, P., Bártová, E., Blanquart, C., Mikros, E., et al. (2014) · MedChemComm · doi:10.1039/c4md00268g · Cited by 7
Network-based insights into miRNA regulation of β-cell insulin secretion in type 2 diabetes
Cowan, E., Karagiannopoulos, A., Pollastri, A., Asai, A., Nagao, M., Maziarz, M., Esguerra, J. L. S., & Eliasson, L. (2025) · iScience · doi:10.1016/j.isci.2025.114200 · Cited by 5
“…several mRNA targets commonly regulated by both miR-101-3p and miR-9-5p, including PDE7B (a modulator of glucose-stimulated insulin secretion 22,46 ), STARD13 (a component of the cytoskeletal organization in islets crucial for glucose-stimulated insulin secretion 47 ), ANK3 (known to regulate…”
Self-citationSong, P.-Y., Li, M.-P., Peng, L., & Chen, X. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100093 · Cited by 4
“[41,42] Most DMLs identified in our study were located in chromosome open sea or intergenic regions.”
Belinda, A., Humardani, F. M., Putra, S. E. D., & Widyadhana, B. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120104 · Cited by 4
Ofori, J. K., Ruhrmann, S., Lindström, A., Perfilyev, A., Martin, M., Karagiannopoulos, A., Scisciola, L., Kost, K., Jönsson, J., Nilsson, Å., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01498-9 · Cited by 5
“Interestingly, NR4A3 and PCSK2 were DEGs in both ADCY9 -deficient islets and in T2D beta cells (Supplementary Tables 10a and 11a).”
InfluentialSelf-citationPark, J. E., Kim, S. Y., & Han, J.-S. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab143 · Cited by 8
Jung, T., Jung, Y., Moon, M. K., Kwon, O., Hwang, G., & Park, T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.814412 · Cited by 5
“Through this application to the KARE dataset, we demonstrate that HisCoM-SM can identify previously reported pathways, including insulin secretion and insulin resistance, associated with T2D, using genetic predispositions of metabolites (Weyer et al., 2001; Dayeh et al., 2014; Kahn et al., 2014).”
Precision Nutrition for Type 2 Diabetes
Ben-Yacov, O., & Rein, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_12 · Cited by 5
Wulfridge, P., Davidovich, A., Salvador, A. C., Manno, G. C., Tryggvadóttir, R., Idrizi, A., Huda, M. N., Bennett, B. J., Adams, L. G., Hansen, K. D., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010997 · Cited by 4
Gao, Q., Huan, C., Jia, Z., Cao, Q., Yuan, P., Li, X., Wang, C., Mao, Z., & Huo, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212113 · Cited by 4
β cells keep bad epigenetic memories of palmitate
Fradin, D., & Bougneres, P. F. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-104 · Cited by 5
“[19] and Volkmar et al.”
Liu, H., Hu, Y., Li, F.-F., Liu, B.-L., Su, X., & Ma, J. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0200-0 · Cited by 6
“All of these genes affect b-cell functions, including insulin production and secretion and b-cell proliferation [8–10]; GLP1R and TCF7L2 were also identified in a-cells and were found to affect glucagon secretion [11, 12].”
Zaina, S., & Lund, G. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0673-y · Cited by 4
Insulin Action, Insulin Resistance, and Their Link to Histone Acetylation
Balcerczyk, A., Chriett, S., & Pirola, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_57 · Cited by 4
Lundberg, M., Stenwall, A., Tegehall, A., Korsgren, O., & Skog, O. (2018) · Islets · doi:10.1080/19382014.2018.1433980 · Cited by 4
Epigenetyczna regulacja ekspresji genów â nowy mechanizm łączący otyłość z rozwojem cukrzycy typu 2
Dobosz, A. M., Dziewulska, A., & Dobrzyń, A. (2018) · Postępy Biochemii · doi:10.18388/pb.2018_126 · Cited by 5
Anticipation of Precision Diabetes and Promise of Integrative Multi-Omics
Liu, C., & Sun, Y. V. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2021.05.011 · Cited by 4
Cystic fibrosis-related diabetes: links, challenges, and future directions
Kelly, A. T., & Sheikh, S. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s68278 · Cited by 6
“Twin studies suggest that the risk of CFRD closely correlates with certain genes associated with T2DM, such as TCF7L2.”
InfluentialMolecular Aspects of Glucose Regulation of Pancreatic β Cells
Gasa, R., Gomis, R., Novials, A., & Servitja, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00013-0 · Cited by 5
Epigenetics of Metabolic Diseases
Gillberg, L., & Hjort, L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805388-1.00037-7 · Cited by 5
Wang, X., Yang, J., Qiu, X., Wen, Q., Liu, M., & Chen, Q. (2020) · Medicine · doi:10.1097/md.0000000000020530 · Cited by 4
Epigenetic and Developmental Basis of Risk of Obesity and Metabolic Disease
Low, F. M., Gluckman, P. D., & Hanson, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819801-8.00014-4 · Cited by 4
Epigenetic and Developmental Basis of Risk of Obesity and Metabolic Disease
Low, F. M., Gluckman, P. D., & Hanson, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408134-5.00008-1 · Cited by 4
Transcriptomics and Epigenomics
Chavan, P., Shah, T., & Joshi, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801814-9.00008-8 · Cited by 6
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_6 · Cited by 6
Gene expression changes in pancreatic α-cell lines following knock-out Of either CK2α or CK2α’
Mayer, J. M., Pack, M., Montenarh, M., & Götz, C. (2025) · Biological Research · doi:10.1186/s40659-025-00654-x · Cited by 3
PLA2G4E in health and disease: Insights from omics and functional analyses
Čater, M., Šimon, M., Morton, N. M., Kunej, T., & Horvat, S. (2025) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101359 · Cited by 4
Zhu, C., Huang, T., Fu, J., Li, M., Tan, L., Zhang, X., Cheng, W., Lai, C., Wang, Z., Zhang, W., et al. (2025) · mSystems · doi:10.1128/msystems.01647-24 · Cited by 4
The effect of polychlorinated biphenyls on type 2 diabetes risk is mediated via DNA methylation
Kartiosuo, N., Auranen, K. J., Mansell, T., Novakovic, B., Nevalainen, J., Pahkala, K., Rovio, S., Mykkänen, J., Viikari, J. S. A., Juonala, M., et al. (2025) · Environment International · doi:10.1016/j.envint.2025.109779 · Cited by 4
Cooper, T. T., & Hess, D. A. (2016) · Endocrinology · doi:10.1210/en.2016-1061 · Cited by 3
Sırıken, B., Sırıken, F., Ünsal, C., & Çiftçi, G. (2018) · Harran Üniversitesi Veteriner Fakültesi Dergisi · doi:10.31196/huvfd.501391 · Cited by 5
Asllanaj, E., Ochoa‐Rosales, C., Glišić, M., Nano, J., Muka, T., & Franco, O. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00012-1 · Cited by 4
Link of gut microbiome with risk of type 2 diabetes mellitus
Alkhammash, A. M., Alshehri, W. A., Alhozali, A. M., & Bahieldin, A. (2022) · Journal of Contemporary Medical Sciences · doi:10.22317/jcms.v8i6.1305 · Cited by 4
Genome plasticity and endocrine diseases
Li, X., Wang, L., Tan, X., & Wang, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817819-5.00013-9 · Cited by 3
Islet Epigenetic Impacts on β‐Cell Identity and Function
Golson, M. L. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200004 · Cited by 3
Mukherjee, A. K., Debbarman, T., Banerjee, B. D., & Siddiqi, S. S. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_43_24 · Cited by 2
Айтбаев, К. А., Калиевна, М. С., Murkamilov, I. T., Fomin, V. V., Kudaibergenova, I., Абдилалимовна, М. Ж., & Yusupov, F. A. (2021) · Bulletin of Science and Practice · doi:10.33619/2414-2948/66/17 · Cited by 2
Nutriepigenomics: Paving the way for personalized nutrition
Park, Y. J., Song, S., Han, Y., & Lindroth, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23802-4.00014-4 · Cited by 2
Dysbiosis–epigenetics–immune system interaction and ageing health problems
Eshkoor, S. A., & Fanijavadi, S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001921 · Cited by 2
Lee, E. J., Lee, H., Kang, J., Kim, K., & Yang, Y.-J. (2025) · Environmental Analysis Health and Toxicology · doi:10.5620/eaht.2025s05 · Cited by 2
“This threshold aligns with prior studies [32-34].”
Targeting endothelial cell metabolism: new therapeutic prospects?
Zecchin, A., Brajic, A., & Carmeliet, P. (2015) · Frontiers in Biology · doi:10.1007/s11515-015-1350-6 · Cited by 3
Rönn, T., Ling, C., & Researcher, A. (2014) · US Endocrinology · doi:10.17925/use.2014.10.01.64 · Cited by 2
Self-citation
Metadata
- Authors
- Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., Bacos, K., & Ling, C.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-06
- Volume
- 10
- Issue
- 3
- Pages
- e1004160
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3945174
- OpenAlex
- W2132464305
- Cited by
- 523
- References
- 90
- Citations by year
- 2026: 25 · 2025: 29 · 2024: 40 · 2023: 49 · 2022: 37 · 2021: 47 · 2020: 30 · 2019: 41 · 2018: 43 · 2017: 47 · 2016: 50 · 2015: 49 · 2014: 34
- FWCI
- 24.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- DNA methylation, pancreatic islets, type 2 diabetes, insulin secretion, glucagon secretion, pancreatic beta cells, alpha cells, epigenetics, differentially methylated genes, p21, PDE7B, SEPT9, TCF7L2, FTO, KCNQ1, promoter methylation, exocytosis, methylome
- MeSH terms
- Insulin Secretion, Diabetes Mellitus, Type 2, Disease Susceptibility, Exocytosis, Humans, Insulin, Islets of Langerhans, Promoter Regions, Genetic, Genome, Human, CpG Islands, DNA Methylation, Epigenesis, Genetic, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.